Guggenheim upgraded MacroGenics to Buy from Neutral with a $12 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MGNX:
- MacroGenics files $300M mixed securities shelf
- MacroGenics reports Q3 EPS 28c, consensus (10c)
- MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial Results
- MGNX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- MacroGenics to Participate in Upcoming Investor Conferences
Questions or Comments about the article? Write to editor@tipranks.com